Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Jazz Pharmaceuticals plc shares valued at $9,826,120 were purchased by Mulligan Seamus on May 09 ’25. At $98.26 per share, Mulligan Seamus acquired 100,000 shares. The insider’s holdings grew to 100,000 shares worth approximately $10.83 million following the completion of this transaction.
Also, Mulligan Seamus purchased 1,621 shares, netting a total of over 166,962 in proceeds. Following the buying of shares at $103.00 each, the insider now holds 101,621 shares.
Before that, COZADD BRUCE C had sold 1,000 shares from its account. In a trade valued at $116,350, the Chairman & CEO traded Jazz Pharmaceuticals plc shares for $116.35 each. Upon closing the transaction, the insider’s holdings decreased to 1,000 shares, worth approximately $47.56 million.
As published in a research note from UBS on March 07, 2025, Jazz Pharmaceuticals plc [JAZZ] has been rated up from a Neutral to a Buy and the price target has been revised to $179 from $145. Analysts at Cantor Fitzgerald downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late February. As of February 13, 2025, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for JAZZ. Earlier on December 12, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for JAZZ stock which previously was a “an Equal-weight”.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 1.58%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -12.08%. Shares of the company reached a 52-week high of $148.06 on 02/26/25 and a 52-week low of $95.49 on 04/09/25.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 106.87, which, if violated, would cause prices to drop to 105.48. In the upper region, resistance lies at 110.83. The next price resistance is at 113.40. RSI (Relative Strength Index) is 47.87 on the 14-day chart, showing neutral technical sentiment.
